Molecular

Sepsis remains one of the most urgent and costly challenges in modern healthcare. Characterized by a life-threatening immune response to infection, sepsis affects an estimated 27 million people and causes 5 million deaths worldwide each year, including approximately 2 million cases and 270,000 deaths in the United States alone. Early detection is critical to survival,…

The global in vitro diagnostics (IVD) market continues to expand in 2025, driven by powerful innovations in next-generation sequencing (NGS), microfluidics, and precision medicine that are transforming diagnostics into a more personalized, patient-centric field. IVD Test Procedure Volumes, 7th Edition (2025-2030) provides a comprehensive, data-driven analysis of global test volume trends, serving as a critical…

The Kalorama Molecular Diagnostics Quarterly Datastream is exclusively available to purchasers of our annual reports: Worldwide In Vitro Diagnostic (IVD) Tests, World Market for Molecular Diagnostics, or Molecular Point-of-Care (mPOC). This quarterly update covers markets detailed in these reports.

The Core Molecular Spectroscopy Techniques Market report provides an in-depth evaluation of UV/Vis, NIR, IR, and Raman spectroscopy from both a primary and secondary market analysis perspective. Each of the four molecular spectroscopy techniques has its own market brief and survey section. The content of this report is complementary to that of the SDi Global Assessment Report,…

With over two decades of experience in publishing in vitro diagnostic (IVD) market research, Kalorama Information presents the 30 Country In Vitro Diagnostics (IVD) Market Atlas, 2024. This quarterly updated report offers a unique approach focused on country-level research and analysis, providing a detailed analysis of major IVD segments forecasted for five years…

The in vitro diagnostics (IVD) market has demonstrated robust growth, driven by technological advancements and expanding opportunities. Diagnostic testing has evolved from merely diagnosing illnesses to providing critical insights for precision medicine treatments. Although COVID-19 testing has declined, it continues to contribute to overall revenues in 2024. The market remains dynamic, influenced by new product…